Berenberg Bank Reiterates Buy Rating for Oxford Nanopore Technologies (LON:ONT)

Berenberg Bank reaffirmed their buy rating on shares of Oxford Nanopore Technologies (LON:ONT) in a research report sent to investors on Wednesday morning, LSE.Co.UK reports. The firm currently has a GBX 350 ($4.36) target price on the stock.

Separately, Citigroup restated a buy rating and set a GBX 210 ($2.61) target price on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, Oxford Nanopore Technologies has an average rating of Buy and an average price target of GBX 303.75 ($3.78).

Oxford Nanopore Technologies Trading Down 3.1 %

LON:ONT opened at GBX 95.80 ($1.19) on Wednesday. The company has a market cap of £823.84 million, a P/E ratio of -659.33 and a beta of 0.59. The stock’s fifty day moving average price is GBX 132.09 and its two-hundred day moving average price is GBX 169.04. Oxford Nanopore Technologies has a 1 year low of GBX 92.20 ($1.15) and a 1 year high of GBX 279 ($3.47). The company has a debt-to-equity ratio of 6.47, a current ratio of 5.01 and a quick ratio of 6.01.

Insider Buying and Selling

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera acquired 39,196 shares of the stock in a transaction that occurred on Wednesday, March 6th. The shares were bought at an average price of GBX 127 ($1.58) per share, for a total transaction of £49,778.92 ($61,968.03). Over the last quarter, insiders have acquired 39,421 shares of company stock worth $5,007,852. Corporate insiders own 30.07% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.